How Can We Modulate Immune Responses to Nanomaterials?
Researchers are developing strategies to modulate immune responses to nanomaterials to maximize therapeutic benefits while minimizing adverse effects. These strategies include:
Surface Modification: Altering surface properties to reduce immune recognition and enhance biocompatibility. Targeting Ligands: Using specific ligands to direct nanoparticles to target cells or tissues, reducing off-target effects. Controlled Release: Designing nanoparticles for controlled and sustained release of therapeutic agents to minimize immune activation. Immunosuppressive Agents: Co-delivery of immunosuppressive drugs to mitigate adverse immune responses.
